Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.
Protein Sci. 2022 Feb;31(2):384-395. doi: 10.1002/pro.4230. Epub 2021 Nov 18.
Lactoperoxidase (1.11.1.7, LPO) is a mammalian heme peroxidase found in the extracellular fluids of mammals including plasma, saliva, airway epithelial lining fluids, nasal lining fluid, milk, tears, gastric juices, and intestinal mucosa. To perform its innate immune action against invading microbes, LPO utilizes hydrogen peroxide (H O ) to convert thiocyanate (SCN ) and iodide (I ) ions into the oxidizing compounds hypothiocyanite (OSCN ) and hypoiodite (IO ). Previously determined structures of the complexes of LPO with SCN , OSCN , and I show that SCN and I occupy appropriate positions in the distal heme cavity as substrates while OSCN binds in the distal heme cavity as a product inhibitor. We report here the structure of the complex of LPO with IO as the first structural evidence of the conversion of iodide into hypoiodite by LPO. To obtain this complex, a solution of LPO was first incubated with H O , then mixed with ammonium iodide solution and the complex crystallized by the addition of PEG-3350, 20% (wt/vol). These crystals were used for X-ray intensity data collection and structure analysis. The structure determination revealed the presence of four hypoiodite ions in the substrate binding channel of LPO. In addition to these, six other hypoiodite ions were observed at different exterior sites. We surmise that the presence of hypoiodite ions in the distal heme cavity blocks the substrate binding site and inhibits catalysis. This was confirmed by activity experiments with the colorimetric substrate, ABTS (2,2'-azino-bis(3-ethylbenzthiazoline-sulfonic acid)), in the presence of hypoiodite and iodide ions.
乳过氧化物酶(1.11.1.7,LPO)是一种哺乳动物血红素过氧化物酶,存在于哺乳动物的细胞外液中,包括血浆、唾液、气道上皮衬里液、鼻衬里液、牛奶、眼泪、胃液和肠黏膜。为了发挥其对入侵微生物的固有免疫作用,LPO 利用过氧化氢(H2O2)将硫氰酸盐(SCN-)和碘化物(I-)离子转化为氧化化合物次碘酸盐(OSCN-)和次碘化物(IO-)。先前确定的 LPO 与 SCN-、OSCN-和 I-复合物的结构表明,SCN-和 I-作为底物占据了远端血红素腔中的适当位置,而 OSCN-作为产物抑制剂结合在远端血红素腔中。我们在这里报告了 LPO 与 IO-复合物的结构,这是 LPO 将碘化物转化为次碘化物的第一个结构证据。为了获得该复合物,首先将 LPO 的溶液与 H2O2 孵育,然后与碘化铵溶液混合,并通过添加 PEG-3350(20%(wt/vol))来结晶该复合物。这些晶体用于 X 射线强度数据收集和结构分析。结构测定揭示了 LPO 的底物结合通道中存在四个次碘酸盐离子。除了这些,还在不同的外部位置观察到了另外六个次碘酸盐离子。我们推测,远端血红素腔中次碘酸盐离子的存在会阻止底物结合位点并抑制催化作用。这通过在存在次碘酸盐和碘化物离子的情况下使用比色底物 ABTS(2,2'- 联氮双(3-乙基苯并噻唑啉-6-磺酸))进行的活性实验得到了证实。